Search filters

List of works by Patricia Aoun

A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival

scientific article published on 7 November 2002

B‐cell lymphoma, unclassifiable, with features intermediate between diffuse large B‐cell lymphoma and burkitt lymphoma: study of 39 cases

scientific article published on April 18, 2013

CD43 expression is associated with inferior survival in the non-germinal centre B-cell subgroup of diffuse large B-cell lymphoma

scientific article published on 25 April 2013

CNOP for diffuse aggressive non-Hodgkin's lymphoma: the Nebraska lymphoma study group experience

scientific article published in April 2002

Cell of origin fails to predict survival in patients with diffuse large B‐cell lymphoma treated with autologous hematopoietic stem cell transplantation

scientific article published on October 18, 2011

Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group

scientific article published on 01 August 2004

Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant hodgkin lymphoma. A report of 21 cases from the Nebraska Lymphoma Study Group

scientific article published on 01 November 2003

Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma

scientific article published on 01 October 2005

Follicular large cleaved cell (centrocytic) lymphoma: An unrecognized variant of follicular lymphoma

scientific article published on 20 November 2017

Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome

scientific article published in April 2015

Lymphoma diagnosis at an academic centre: rate of revision and impact on patient care

scientific article published on 04 April 2014

MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab

scientific article published on 08 February 2014

Rituximab Improves the Outcome of Patients With Grade 3 Follicular Lymphoma Receiving Anthracycline-Based Therapy

scientific article published on 16 June 2017